Description
Lenvatinib is a powerful multi-kinase inhibitor used to treat advanced cancers, including thyroid, liver, and kidney cancers. It works by blocking tumor angiogenesis and cell proliferation, effectively slowing disease progression and extending survival in patients with difficult-to-treat solid tumors.